Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19

Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19

Abstract Since December 2019, a novel type of coronavirus disease (COVID-19) in Wuhan led to an outbreak throughout China and the rest of the world. To date, there have been more than 1,260,000 COVID-19 patients, with a mortality rate of approximately 5.44%. Studies have shown that coagulation dysfu...

Full description

Bibliographic Details
Main Authors: Jing-Chun Song, Gang Wang, Wei Zhang, Yang Zhang, Wei-Qin Li, Zhou Zhou, People’s Liberation Army Professional Committee of Critical Care Medicine, Chinese Society on Thrombosis and Haemostasis
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Military Medical Research
Subjects:
COVID-19
Severe
Coagulation dysfunction
Diagnosis
Treatment
Online Access:http://link.springer.com/article/10.1186/s40779-020-00247-7

Internet

http://link.springer.com/article/10.1186/s40779-020-00247-7

Similar Items